Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases — Stella

Home/Healthy Volunteers/

View on ClinicalTrials.gov

Recruiting

Back to Healthy Volunteers trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United Kingdom

Parexel Research Unit, Harrow

Key details

Phase

Early testing

Sponsor

Novo Nordisk A/S

Enrollment target

~48 participants

Started

March 2025

Primary completion

October 2027

Age range

18 Years – 64 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.